Liver epithelial cells inhibit proliferation and invasiveness of hepatoma cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Oncology Report

• Publication date

  2016-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2015.4478PMID 26647726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system

  2015cited by this paper
• Heterogeneity of hepatocellular carcinoma contributes to cancer progression.

  2015cited by this paper
• Extracellular Molecules Involved in Cancer Cell Invasion

  2015cited by this paper
• The therapeutic potential of bone marrow‐derived mesenchymal stromal cells on hepatocellular carcinoma

  2014cited by this paper
• HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway.

  2014cited by this paper
• Hepatocellular carcinoma review: current treatment, and evidence-based medicine.

  2014cited by this paper
• Hepatocellular carcinoma: A comprehensive overview of surgical therapy

  2014cited by this paper
• Microvesicles Derived from Human Bone Marrow Mesenchymal Stem Cells Inhibit Tumor Growth

  2013cited by this paper
• Effect of human mesenchymal stem cells on the growth of HepG2 and Hela cells.

  2013cited by this paper
• Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis

  2013cited by this paper
• Human Bone Marrow‐Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis

  2013cited by this paper
• Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.

  2013influential reference
• Isolation of EpCAM+/CD133− hepatic progenitor cells

  2013influential reference
• Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma

  2013cited by this paper
• Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

  2013cited by this paper
• Retracted: Tumor Tropism of Intravenously Injected Human‐Induced Pluripotent Stem Cell‐Derived Neural Stem Cells and Their Gene Therapy Application in a Metastatic Breast Cancer Model

  2012cited by this paper
• The role of the tumor microenvironment in regulating angiogenesis.

  2012cited by this paper
• Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications.

  2012cited by this paper
• Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response

  2010cited by this paper
• Hepatocytic precursor (stem-like) WB-F344 cells reduce tumorigenicity of hepatoma CBRH-7919 cells via TGF-beta/Smad pathway.

  2010influential reference
• The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

  2010cited by this paper
• Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma

  2010influential reference
• Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97‐H cell line

  2010cited by this paper
• Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation.

  2009cited by this paper
• The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo

  2008cited by this paper
• Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting

  2008cited by this paper
• Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model

  2008cited by this paper
• Novel hepatic progenitor cell surface markers in the adult rat liver

  2007influential reference
• Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth

  2007cited by this paper
• Selective tropism of liver stem cells to hepatocellular carcinoma in vivo.

  2007influential reference
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities

  2007cited by this paper
• Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

  2006cited by this paper
• Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

  2006cited by this paper
• Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1.

  2006cited by this paper
• Anti‐tumor activity of mesenchymal stem cells producing IL‐12 in a mouse melanoma model

  2006cited by this paper
• Tumour-cell invasion and migration: diversity and escape mechanisms

  2003cited by this paper
• Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

  2003cited by this paper
• Hepatic oval cells express the hematopoietic stem cell marker thy‐1 in the rat

  1998influential reference
• A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells.

  1984cited by this paper

• Tropism of liver epithelial cells toward hepatocellular carcinoma in vitro and in vivo with altering gene expression of cancer stem cells.

  2017cites this paper